Application 018709

Type: NDA
Sponsor: APOTHECON

Application Products#

Product, Drug, Ingredient table
Product	Drug	Ingredient	Form	Strength	Reference drug	Reference standard
001	CAPOZIDE 25/15	CAPTOPRIL; HYDROCHLOROTHIAZIDE	TABLET;ORAL	25MG;15MG Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons	Yes	No
002	CAPOZIDE 25/25	CAPTOPRIL; HYDROCHLOROTHIAZIDE	TABLET;ORAL	25MG;25MG Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons	Yes	No
003	CAPOZIDE 50/25	CAPTOPRIL; HYDROCHLOROTHIAZIDE	TABLET;ORAL	50MG;25MG Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons	Yes	No
004	CAPOZIDE 50/15	CAPTOPRIL; HYDROCHLOROTHIAZIDE	TABLET;ORAL	50MG;15MG Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons	Yes	No

Source provenance: Browse the complete Orange Book source catalog · source snapshot 44.

Orange Book products#

Current product rows page 1 of 1 · 4 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	RLD / RS	Approval date
N018709-001	CAPOZIDE 25/15	CAPTOPRIL; HYDROCHLOROTHIAZIDE	25MG;15MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET / ORAL	RLD	1984-10-12
N018709-002	CAPOZIDE 25/25	CAPTOPRIL; HYDROCHLOROTHIAZIDE	25MG;25MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET / ORAL	RLD	1984-10-12
N018709-003	CAPOZIDE 50/25	CAPTOPRIL; HYDROCHLOROTHIAZIDE	50MG;25MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET / ORAL	RLD	1984-10-12
N018709-004	CAPOZIDE 50/15	CAPTOPRIL; HYDROCHLOROTHIAZIDE	50MG;15MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET / ORAL	RLD	1984-10-12

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 3 of 5 · 176 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	RLD / RS	Approval date	Source SHA-256
2019-12-13 00:20 UTC	2019-12	N018709-001	CAPOZIDE 25/15	25MG;15MG Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons	TABLET / ORAL	RLD	1984-10-12	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	N018709-002	CAPOZIDE 25/25	25MG;25MG Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons	TABLET / ORAL	RLD	1984-10-12	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	N018709-003	CAPOZIDE 50/25	50MG;25MG Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons	TABLET / ORAL	RLD	1984-10-12	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	N018709-004	CAPOZIDE 50/15	50MG;15MG Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons	TABLET / ORAL	RLD	1984-10-12	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	N018709-001	CAPOZIDE 25/15	25MG;15MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET / ORAL	RLD	1984-10-12	`bb7c543d1eb4…`
2022-03-09 01:35 UTC	2022-03	N018709-002	CAPOZIDE 25/25	25MG;25MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET / ORAL	RLD	1984-10-12	`bb7c543d1eb4…`
2022-03-09 01:35 UTC	2022-03	N018709-003	CAPOZIDE 50/25	50MG;25MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET / ORAL	RLD	1984-10-12	`bb7c543d1eb4…`
2022-03-09 01:35 UTC	2022-03	N018709-004	CAPOZIDE 50/15	50MG;15MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET / ORAL	RLD	1984-10-12	`bb7c543d1eb4…`
2021-12-28 21:50 UTC	2021-12	N018709-001	CAPOZIDE 25/15	25MG;15MG Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons	TABLET / ORAL	RLD	1984-10-12	`782e0a99824c…`
2021-12-28 21:50 UTC	2021-12	N018709-002	CAPOZIDE 25/25	25MG;25MG Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons	TABLET / ORAL	RLD	1984-10-12	`782e0a99824c…`
2021-12-28 21:50 UTC	2021-12	N018709-003	CAPOZIDE 50/25	50MG;25MG Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons	TABLET / ORAL	RLD	1984-10-12	`782e0a99824c…`
2021-12-28 21:50 UTC	2021-12	N018709-004	CAPOZIDE 50/15	50MG;15MG Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons	TABLET / ORAL	RLD	1984-10-12	`782e0a99824c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	N018709-001	CAPOZIDE 25/15	25MG;15MG Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons	TABLET / ORAL	RLD	1984-10-12	`87673890dc5c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	N018709-002	CAPOZIDE 25/25	25MG;25MG Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons	TABLET / ORAL	RLD	1984-10-12	`87673890dc5c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	N018709-003	CAPOZIDE 50/25	50MG;25MG Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons	TABLET / ORAL	RLD	1984-10-12	`87673890dc5c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	N018709-004	CAPOZIDE 50/15	50MG;15MG Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons	TABLET / ORAL	RLD	1984-10-12	`87673890dc5c…`
2021-03-12 10:30 UTC	2021-03	N018709-001	CAPOZIDE 25/15	25MG;15MG Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons	TABLET / ORAL	RLD	1984-10-12	`5aa47cf7b7d7…`
2021-03-12 10:30 UTC	2021-03	N018709-002	CAPOZIDE 25/25	25MG;25MG Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons	TABLET / ORAL	RLD	1984-10-12	`5aa47cf7b7d7…`
2021-03-12 10:30 UTC	2021-03	N018709-003	CAPOZIDE 50/25	50MG;25MG Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons	TABLET / ORAL	RLD	1984-10-12	`5aa47cf7b7d7…`
2021-03-12 10:30 UTC	2021-03	N018709-004	CAPOZIDE 50/15	50MG;15MG Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons	TABLET / ORAL	RLD	1984-10-12	`5aa47cf7b7d7…`
2020-12-22 03:56 UTC	2020-12	N018709-001	CAPOZIDE 25/15	25MG;15MG Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons	TABLET / ORAL	RLD	1984-10-12	`8869cabd3fbd…`
2020-12-22 03:56 UTC	2020-12	N018709-002	CAPOZIDE 25/25	25MG;25MG Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons	TABLET / ORAL	RLD	1984-10-12	`8869cabd3fbd…`
2020-12-22 03:56 UTC	2020-12	N018709-003	CAPOZIDE 50/25	50MG;25MG Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons	TABLET / ORAL	RLD	1984-10-12	`8869cabd3fbd…`
2020-12-22 03:56 UTC	2020-12	N018709-004	CAPOZIDE 50/15	50MG;15MG Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons	TABLET / ORAL	RLD	1984-10-12	`8869cabd3fbd…`
2020-11-12 02:37 UTC	2020-11	N018709-001	CAPOZIDE 25/15	25MG;15MG Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons	TABLET / ORAL	RLD	1984-10-12	`c0c555d07b60…`
2020-11-12 02:37 UTC	2020-11	N018709-002	CAPOZIDE 25/25	25MG;25MG Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons	TABLET / ORAL	RLD	1984-10-12	`c0c555d07b60…`
2020-11-12 02:37 UTC	2020-11	N018709-003	CAPOZIDE 50/25	50MG;25MG Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons	TABLET / ORAL	RLD	1984-10-12	`c0c555d07b60…`
2020-11-12 02:37 UTC	2020-11	N018709-004	CAPOZIDE 50/15	50MG;15MG Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons	TABLET / ORAL	RLD	1984-10-12	`c0c555d07b60…`
2019-12-14 00:12 UTC	2019-12	N018709-001	CAPOZIDE 25/15	25MG;15MG Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons	TABLET / ORAL	RLD	1984-10-12	`3f01610625f2…`
2019-12-14 00:12 UTC	2019-12	N018709-002	CAPOZIDE 25/25	25MG;25MG Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons	TABLET / ORAL	RLD	1984-10-12	`3f01610625f2…`
2019-12-14 00:12 UTC	2019-12	N018709-003	CAPOZIDE 50/25	50MG;25MG Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons	TABLET / ORAL	RLD	1984-10-12	`3f01610625f2…`
2019-12-14 00:12 UTC	2019-12	N018709-004	CAPOZIDE 50/15	50MG;15MG Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons	TABLET / ORAL	RLD	1984-10-12	`3f01610625f2…`
2019-09-15 20:21 UTC	2019-09	N018709-001	CAPOZIDE 25/15	25MG;15MG Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons	TABLET / ORAL	RLD	1984-10-12	`b00525d2431f…`
2019-09-15 20:21 UTC	2019-09	N018709-002	CAPOZIDE 25/25	25MG;25MG Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons	TABLET / ORAL	RLD	1984-10-12	`b00525d2431f…`
2019-09-15 20:21 UTC	2019-09	N018709-003	CAPOZIDE 50/25	50MG;25MG Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons	TABLET / ORAL	RLD	1984-10-12	`b00525d2431f…`
2019-09-15 20:21 UTC	2019-09	N018709-004	CAPOZIDE 50/15	50MG;15MG Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons	TABLET / ORAL	RLD	1984-10-12	`b00525d2431f…`
2019-07-19 19:46 UTC	2019-07	N018709-001	CAPOZIDE 25/15	25MG;15MG Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons	TABLET / ORAL	RLD	1984-10-12	`ea99ee380514…`
2019-07-19 19:46 UTC	2019-07	N018709-002	CAPOZIDE 25/25	25MG;25MG Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons	TABLET / ORAL	RLD	1984-10-12	`ea99ee380514…`
2019-07-19 19:46 UTC	2019-07	N018709-003	CAPOZIDE 50/25	50MG;25MG Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons	TABLET / ORAL	RLD	1984-10-12	`ea99ee380514…`
2019-07-19 19:46 UTC	2019-07	N018709-004	CAPOZIDE 50/15	50MG;15MG Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons	TABLET / ORAL	RLD	1984-10-12	`ea99ee380514…`

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

Documents#

Document, Submission type, Date table
Document	Submission type	Date
1044	SUPPL	2009-03-03
1043	SUPPL	2006-05-21